Company Profile
Waters Corporation is a US-based manufacturer of analytical instruments and clinical diagnostic systems, headquartered in Milford, Massachusetts, USA. Founded in 1958 by James Logan Waters, the company operates as a publicly listed entity on the New York Stock Exchange (NYSE: WAT) with approximately 7,900+ employees (pre-combination), serving global life sciences, materials, food, and environmental markets in over 100 countries.
Core Products ＆ Technologies
Analytical Sciences
• ACQUITY UPLC Systems: Ultra-performance liquid chromatography platforms for high-resolution separations in pharmaceutical and biopharmaceutical analysis
• Xevo Mass Spectrometry: Tandem quadrupole (TQ) and time-of-flight (Q-Tof) MS systems for quantitative and qualitative molecular characterization
• Chromatography Columns ＆ Chemistry: UPLC/HPLC columns, sample preparation consumables, and chemistry products for method development and routine testing
Advanced Diagnostics ＆ IVD
• MassTrak IVD Systems: LC-MS/MS medical devices for clinical diagnostics including endocrinology, toxicology, therapeutic drug monitoring, and metabolic screening
• ACQUITY UPLC I-Class/Xevo TQ-S micro IVD: Compact IVD system for low-concentration quantification in clinical laboratories
• RenataDX System: Fully integrated FIA-MS/MS IVD platform for dried blood spot (DBS) analysis in neonatal screening
• Microbiology ＆ Molecular Diagnostics: Automated identification and susceptibility systems, molecular assays, and point-of-care testing platforms (via BD Diagnostic Solutions combination)
Biosciences ＆ Materials
• Flow Cytometry ＆ Cell Sorting: Analytical and cell sorting instruments with reagents for cellular research and clinical diagnostics (via BD Biosciences combination)
• Single-Cell Multiomics: Solutions for genomic, transcriptomic, and proteomic analysis at single-cell resolution
• Thermal Analysis ＆ Rheometry: Instruments for materials characterization in batteries, electronics, and pharmaceutical applications
Market Position ＆ Certifications
Waters holds a global leadership position in the liquid chromatography and mass spectrometry market, competing with Agilent Technologies, Thermo Fisher Scientific, and Danaher Corporation. Key strengths include:
• 68 years of US analytical science heritage since founding
• BD combination: Completed $18.8 billion combination with BD's Biosciences ＆ Diagnostic Solutions on February 9, 2026, creating four divisions and expanding into flow cytometry, microbiology, and molecular diagnostics
• Regulatory compliance: IVD systems compliant with EU IVDR, FDA QSR, ISO 13485:2016, and 21 CFR Part 820
• Integrated portfolio: Four divisions spanning analytical sciences, biosciences, advanced diagnostics, and materials sciences
• Financial scale: 2025 revenue $3.17 billion; Q1 2026 revenue $1.27 billion; 2026 full-year guidance raised to $6.41–$6.46 billion
Corporate Timeline
1958 — Founded in Framingham, Massachusetts, USA, by James Logan Waters
1960s-70s — Pioneered commercial HPLC systems and established global chromatography leadership
1995 — Listed on the New York Stock Exchange (NYSE: WAT)
2025 — Full-year revenue reached $3.17 billion with 7% growth; launched Alliance iS HPLC System
2026 — Completed combination with BD's Biosciences ＆ Diagnostic Solutions (February 9), forming four divisions; Q1 revenue $1.27 billion exceeded guidance; raised 2026 full-year revenue guidance to $6.41–$6.46 billion and adjusted EPS to $14.40–$14.60
Target Markets ＆ Applications
• Pharmaceutical ＆ Biopharmaceutical: UPLC-MS for drug discovery, development, quality control, and bioprocess monitoring
• Clinical Diagnostics: LC-MS/MS IVD systems for neonatal screening, endocrinology, toxicology, and therapeutic drug monitoring
• Food Safety ＆ Environmental: Trace contaminant detection, pesticide analysis, and water quality monitoring
• Materials Science: Thermal analysis and rheometry for battery, polymer, and electronics characterization
• Cellular Research: Flow cytometry and single-cell multiomics for immunology and oncology research
Contact Information
Global Headquarters
Address: 34 Maple Street, Milford, MA 01757, USA
Telephone: +1 508 478-2000
Toll Free: 1-800-252-HPLC (4752)
Fax: +1 508 872-1990
Corporate Status
Entity Type: Publicly Listed Company (No Parent Company)
Stock: NYSE: WAT
Website: waters.com
Investor Relations: ir.waters.com
